Journal of Comprehensive Pediatrics

Published by: Kowsar

Brain Natriuretic Peptide as a Novel Diagnostic Biomarker in Kawasaki Disease

Kazunari Kaneko 1 , * , Ken Yoshimura 1 and Shoji Tsuji 1
Authors Information
1 Department of Pediatrics, Kansai Medical University, Osaka, Japan
Article information
  • Journal of Comprehensive Pediatrics: November 01, 2014, 5 (4); e19505
  • Published Online: August 5, 2014
  • Article Type: Editorial
  • Received: May 28, 2014
  • Revised: May 28, 2014
  • Accepted: June 3, 2014
  • DOI: 10.17795/compreped-19505

To Cite: Kaneko K, Yoshimura K, Tsuji S. Brain Natriuretic Peptide as a Novel Diagnostic Biomarker in Kawasaki Disease, J Compr Ped. 2014 ; 5(4):e19505. doi: 10.17795/compreped-19505.

Copyright © 2014, Iranian Society of Pediatrics. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Footnotes
References
  • 1. Burns JC, Glode MP. Kawasaki syndrome. Lancet. 2004; 364(9433): 533-44[DOI][PubMed]
  • 2. Soleimani G, Sadeghi Bojd S, Tajik M, Shafighi Shahri E, Rashidi S. Paraclinical Evolutions Regarding Liver and Renal Abnormalities of Kawasaki Disease in the Southeast of Iran. J Compr Ped. 2014; 5(1)
  • 3. Sedighi I, Biglari M, Olfat M, Yadolahi H, Tanasan A, Torabian S. Clinical Characteristics and Outcomes of Iranian Patients With Kawasaki Diasease. J Compr Ped. 2014; 5(1)
  • 4. Sudo D, Monobe Y, Yashiro M, Mieno MN, Uehara R, Tsuchiya K, et al. Coronary artery lesions of incomplete Kawasaki disease: a nationwide survey in Japan. Eur J Pediatr. 2012; 171(4): 651-6[DOI][PubMed]
  • 5. Chopra S, Cherian D, Verghese PP, Jacob JJ. Physiology and clinical significance of natriuretic hormones. Indian J Endocrinol Metab. 2013; 17(1): 83-90[DOI][PubMed]
  • 6. Cho SY, Kim Y, Cha SH, Suh JT, Han MY, Lee HJ. Adjuvant laboratory marker of Kawasaki disease; NT-pro-BNP or hs-CRP? Ann Clin Lab Sci. 2011; 41(4): 360-3[PubMed]
  • 7. Dahdah N, Siles A, Fournier A, Cousineau J, Delvin E, Saint-Cyr C, et al. Natriuretic peptide as an adjunctive diagnostic test in the acute phase of Kawasaki disease. Pediatr Cardiol. 2009; 30(6): 810-7[DOI][PubMed]
  • 8. Kawamura T, Wago M, Kawaguchi H, Tahara M, Yuge M. Plasma brain natriuretic peptide concentrations in patients with Kawasaki disease. Pediatr Int. 2000; 42(3): 241-8[PubMed]
  • 9. Kishimoto S, Suda K, Teramachi Y, Nishino H, Kudo Y, Ishii H, et al. Increased plasma type B natriuretic peptide in the acute phase of Kawasaki disease. Pediatr Int. 2011; 53(5): 736-41[DOI][PubMed]
  • 10. McNeal-Davidson A, Fournier A, Spigelblatt L, Saint-Cyr C, Mir TS, Nir A, et al. Value of amino-terminal pro B-natriuretic peptide in diagnosing Kawasaki disease. Pediatr Int. 2012; 54(5): 627-33[DOI][PubMed]
  • 11. Shiraishi M, Fuse S, Mori T, Doyama A, Honjyo S, Hoshino Y, et al. N-terminal pro-brain natriuretic Peptide as a useful diagnostic marker of acute Kawasaki disease in children. Circ J. 2013; 77(8): 2097-101[PubMed]
  • 12. Soldin SJ, Soldin OP, Boyajian AJ, Taskier MS. Pediatric brain natriuretic peptide and N-terminal pro-brain natriuretic peptide reference intervals. Clin Chim Acta. 2006; 366(1-2): 304-8[DOI][PubMed]
  • 13. Yoshimura K, Kimata T, Mine K, Uchiyama T, Tsuji S, Kaneko K. N-terminal pro-brain natriuretic peptide and risk of coronary artery lesions and resistance to intravenous immunoglobulin in Kawasaki disease. J Pediatr. 2013; 162(6): 1205-9[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments